Found 50 Enz. Inhib. hit(s) with all data for entry = 50033943 
Affinity DataKi: 2.50E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 3.30E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 3.30E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 3.60E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 4.00E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 4.40E+3nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 4.40E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 4.50E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 5.40E+3nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 6.00E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 7.20E+3nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 7.40E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 8.95E+3nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 9.00E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 9.10E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 9.50E+3nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 9.70E+3nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 1.00E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.01E+4nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.02E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.03E+4nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 1.05E+4nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 1.08E+4nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 1.11E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.13E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.19E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.19E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.30E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.38E+4nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 1.48E+4nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.56E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 1.66E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.19E+4nMAssay Description:Partial mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as su...More data for this Ligand-Target Pair
Affinity DataKi: 2.30E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.30E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.43E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.83E+4nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 3.41E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 4.07E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 4.67E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 4.94E+4nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 5.16E+4nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 7.06E+4nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 9.71E+4nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.08E+5nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.12E+5nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.21E+5nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 2.59E+5nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 3.51E+5nMAssay Description:Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
Affinity DataKi: 5.60E+5nMAssay Description:Reversible inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate ...More data for this Ligand-Target Pair
